chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: Itchiness at site of injection; Red rash at site of injection; Swelling at site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchiness at site of injection), VACCINATION SITE RASH (Red rash at site of injection) and VACCINATION SITE SWELLING (Swelling at site of injection) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness at site of injection), VACCINATION SITE RASH (Red rash at site of injection) and VACCINATION SITE SWELLING (Swelling at site of injection). On 08-Mar-2021, VACCINATION SITE PRURITUS (Itchiness at site of injection), VACCINATION SITE RASH (Red rash at site of injection) and VACCINATION SITE SWELLING (Swelling at site of injection) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications and treatment medications were not reported. Patient declined to give information for further follow up.   Reporter did not allow further contact
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia
Clinical narrative: Fever; Tired; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and FATIGUE (Tired) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 28-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever) and FATIGUE (Tired). At the time of the report, PYREXIA (Fever) and FATIGUE (Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Gait disturbance, Headache, Influenza like illness, Pain
Clinical narrative: feels like she has the flu; feels terrible; whole body aching/e verything hurts; can hardly walk; a headache; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (feels like she has the flu), FEELING ABNORMAL (feels terrible), PAIN (whole body aching/e verything hurts), GAIT DISTURBANCE (can hardly walk) and HEADACHE (a headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ALPRAZOLAM (XANAX), OXCARBAZEPINE (TRILEPTAL) and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.   On 07-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (feels like she has the flu), FEELING ABNORMAL (feels terrible), PAIN (whole body aching/e verything hurts), GAIT DISTURBANCE (can hardly walk) and HEADACHE (a headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (feels like she has the flu), FEELING ABNORMAL (feels terrible), PAIN (whole body aching/e verything hurts), GAIT DISTURBANCE (can hardly walk) and HEADACHE (a headache) outcome was unknown.            Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) is considered as not applicable.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Injection site swelling, Injection site urticaria
Clinical narrative: raised and hard; continued to have hives at the site of injection; It was very swollen; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (raised and hard), INJECTION SITE URTICARIA (continued to have hives at the site of injection) and INJECTION SITE SWELLING (It was very swollen) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0104217) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DISCOMFORT (raised and hard), INJECTION SITE URTICARIA (continued to have hives at the site of injection) and INJECTION SITE SWELLING (It was very swollen). At the time of the report, DISCOMFORT (raised and hard), INJECTION SITE URTICARIA (continued to have hives at the site of injection) and INJECTION SITE SWELLING (It was very swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were provided
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Burning sensation, Injection site hypersensitivity
Clinical narrative: Redness and breaking skin around sweat glands; burning sensation; knee pain; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE HYPERSENSITIVITY (Redness and breaking skin around sweat glands), BURNING SENSATION (burning sensation) and ARTHRALGIA (knee pain) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 010M20A.) for COVID-19 vaccination.     Concomitant products included BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) and LORAZEPAM for an unknown indication.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced INJECTION SITE HYPERSENSITIVITY (Redness and breaking skin around sweat glands), BURNING SENSATION (burning sensation) and ARTHRALGIA (knee pain). At the time of the report, INJECTION SITE HYPERSENSITIVITY (Redness and breaking skin around sweat glands), BURNING SENSATION (burning sensation) and ARTHRALGIA (knee pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No Concomitant medications were provided No Treatment information provided
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at the injection site) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M21A and 010M20A) for COVID-19 vaccination.     The patient's past medical history included Arthritis since an unknown date. Concomitant products included BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) and LORAZEPAM for an unknown indication.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (pain at the injection site). At the time of the report, VACCINATION SITE PAIN (pain at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: arm pain; like balls (injection site); bruising on her arm at the injection site; redness; body aches/ very bad, the pain is unbearable; unbearable headache; fever over 100°F; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain), VACCINATION SITE ABSCESS (like balls (injection site)), VACCINATION SITE BRUISING (bruising on her arm at the injection site), VACCINATION SITE ERYTHEMA (redness) and MYALGIA (body aches/ very bad, the pain is unbearable) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm pain), VACCINATION SITE ABSCESS (like balls (injection site)), VACCINATION SITE BRUISING (bruising on her arm at the injection site), VACCINATION SITE ERYTHEMA (redness), MYALGIA (body aches/ very bad, the pain is unbearable), HEADACHE (unbearable headache), PYREXIA (fever over 100°F) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm pain), VACCINATION SITE ABSCESS (like balls (injection site)), VACCINATION SITE BRUISING (bruising on her arm at the injection site), VACCINATION SITE ERYTHEMA (redness), MYALGIA (body aches/ very bad, the pain is unbearable), HEADACHE (unbearable headache), PYREXIA (fever over 100°F) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Mar-2021, Body temperature: 100 (High) 100°F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site abscess, Vaccination site bruising, Vaccination site erythema
Clinical narrative: arm pain; like balls (injection site); bruising on her arm at the injection site; redness; body aches/ very bad, the pain is unbearable; unbearable headache; fever over 100°F; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain), VACCINATION SITE ABSCESS (like balls (injection site)), VACCINATION SITE BRUISING (bruising on her arm at the injection site), VACCINATION SITE ERYTHEMA (redness) and MYALGIA (body aches/ very bad, the pain is unbearable) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm pain), VACCINATION SITE ABSCESS (like balls (injection site)), VACCINATION SITE BRUISING (bruising on her arm at the injection site), VACCINATION SITE ERYTHEMA (redness), MYALGIA (body aches/ very bad, the pain is unbearable), HEADACHE (unbearable headache), PYREXIA (fever over 100°F) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm pain), VACCINATION SITE ABSCESS (like balls (injection site)), VACCINATION SITE BRUISING (bruising on her arm at the injection site), VACCINATION SITE ERYTHEMA (redness), MYALGIA (body aches/ very bad, the pain is unbearable), HEADACHE (unbearable headache), PYREXIA (fever over 100°F) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Mar-2021, Body temperature: 100 (High) 100°F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Vaccination site rash
Clinical narrative: rash about a quarter of an inch below the injection site; soreness in the arm; soreness/achiness on her left side; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in the arm), PAIN (soreness/achiness on her left side) and VACCINATION SITE RASH (rash about a quarter of an inch below the injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for an unknown indication.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 ml. On 27-Feb-2021, the patient experienced PAIN IN EXTREMITY (soreness in the arm) and PAIN (soreness/achiness on her left side). On 07-Mar-2021, the patient experienced VACCINATION SITE RASH (rash about a quarter of an inch below the injection site). On 01-Mar-2021, PAIN IN EXTREMITY (soreness in the arm) and PAIN (soreness/achiness on her left side) had resolved. At the time of the report, VACCINATION SITE RASH (rash about a quarter of an inch below the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
Age: 88.0
Sex: U
Vaccine: COVID19
Symptoms: Asthenia, Chills, Dyspnoea, Headache, Pain
Clinical narrative: swollen throat; trouble breathing; weakness; body aches; chills; headache; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), PHARYNGEAL SWELLING (swollen throat), DYSPNOEA (trouble breathing), ASTHENIA (weakness) and PAIN (body aches) in an 88-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and HEADACHE (headache). On 08-Mar-2021, the patient experienced PHARYNGEAL SWELLING (swollen throat), DYSPNOEA (trouble breathing), ASTHENIA (weakness), PAIN (body aches) and CHILLS (chills). On 04-Mar-2021, PAIN IN EXTREMITY (sore arm) and HEADACHE (headache) had resolved. At the time of the report, PHARYNGEAL SWELLING (swollen throat), DYSPNOEA (trouble breathing), ASTHENIA (weakness), PAIN (body aches) and CHILLS (chills) was resolving.            The patient took the second dose of the mRNA-1273, hence action taken with the vaccine in response to the events was not applicable.   No concomitant medication was reported.  No treatment medication was reported.
Age: 88.0
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity, Pharyngeal swelling
Clinical narrative: swollen throat; trouble breathing; weakness; body aches; chills; headache; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), PHARYNGEAL SWELLING (swollen throat), DYSPNOEA (trouble breathing), ASTHENIA (weakness) and PAIN (body aches) in an 88-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and HEADACHE (headache). On 08-Mar-2021, the patient experienced PHARYNGEAL SWELLING (swollen throat), DYSPNOEA (trouble breathing), ASTHENIA (weakness), PAIN (body aches) and CHILLS (chills). On 04-Mar-2021, PAIN IN EXTREMITY (sore arm) and HEADACHE (headache) had resolved. At the time of the report, PHARYNGEAL SWELLING (swollen throat), DYSPNOEA (trouble breathing), ASTHENIA (weakness), PAIN (body aches) and CHILLS (chills) was resolving.            The patient took the second dose of the mRNA-1273, hence action taken with the vaccine in response to the events was not applicable.   No concomitant medication was reported.  No treatment medication was reported.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Oral herpes, Pain in extremity
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of oral herpes (cold sore), pain in extremity (sore arm) and fatigue in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Mar 5, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 5, 2021, patient experienced oral herpes (cold sore), pain in extremity (sore arm) and fatigue. At the time of the report, oral herpes (cold sore), pain in extremity (sore arm) and fatigue outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Dysstasia, Headache, Muscle spasms
Clinical narrative: Mass around injection site; Center of injection site had deeper color; Light headedness; Muscle Cramping; Unable to stand; Heart racing; Rash at injection site; Injection site was red; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), HEADACHE (Headache), VACCINATION SITE MASS (Mass around injection site), VACCINATION SITE ERYTHEMA (Injection site was red) and VACCINATION SITE DISCOLOURATION (Center of injection site had deeper color) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced CHILLS (Chills), HEADACHE (Headache), VACCINATION SITE MASS (Mass around injection site), VACCINATION SITE ERYTHEMA (Injection site was red), VACCINATION SITE DISCOLOURATION (Center of injection site had deeper color), VACCINATION SITE RASH (Rash at injection site), DIZZINESS (Light headedness), MUSCLE SPASMS (Muscle Cramping), DYSSTASIA (Unable to stand) and PALPITATIONS (Heart racing). At the time of the report, CHILLS (Chills), HEADACHE (Headache), VACCINATION SITE MASS (Mass around injection site), VACCINATION SITE ERYTHEMA (Injection site was red), VACCINATION SITE DISCOLOURATION (Center of injection site had deeper color), VACCINATION SITE RASH (Rash at injection site), DIZZINESS (Light headedness), MUSCLE SPASMS (Muscle Cramping), DYSSTASIA (Unable to stand) and PALPITATIONS (Heart racing) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Vaccination site discolouration, Vaccination site erythema, Vaccination site mass, Vaccination site rash
Clinical narrative: Mass around injection site; Center of injection site had deeper color; Light headedness; Muscle Cramping; Unable to stand; Heart racing; Rash at injection site; Injection site was red; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), HEADACHE (Headache), VACCINATION SITE MASS (Mass around injection site), VACCINATION SITE ERYTHEMA (Injection site was red) and VACCINATION SITE DISCOLOURATION (Center of injection site had deeper color) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced CHILLS (Chills), HEADACHE (Headache), VACCINATION SITE MASS (Mass around injection site), VACCINATION SITE ERYTHEMA (Injection site was red), VACCINATION SITE DISCOLOURATION (Center of injection site had deeper color), VACCINATION SITE RASH (Rash at injection site), DIZZINESS (Light headedness), MUSCLE SPASMS (Muscle Cramping), DYSSTASIA (Unable to stand) and PALPITATIONS (Heart racing). At the time of the report, CHILLS (Chills), HEADACHE (Headache), VACCINATION SITE MASS (Mass around injection site), VACCINATION SITE ERYTHEMA (Injection site was red), VACCINATION SITE DISCOLOURATION (Center of injection site had deeper color), VACCINATION SITE RASH (Rash at injection site), DIZZINESS (Light headedness), MUSCLE SPASMS (Muscle Cramping), DYSSTASIA (Unable to stand) and PALPITATIONS (Heart racing) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Flushing, Headache, Lymphadenopathy
Clinical narrative: flush; joint pain; chills; headache; swollen lymph nodes above clavicle; muscle aches; fever; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (flush), ARTHRALGIA (joint pain), CHILLS (chills), HEADACHE (headache) and LYMPHADENOPATHY (swollen lymph nodes above clavicle) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced FLUSHING (flush), ARTHRALGIA (joint pain), CHILLS (chills), HEADACHE (headache), LYMPHADENOPATHY (swollen lymph nodes above clavicle), MYALGIA (muscle aches) and PYREXIA (fever). On 05-Mar-2021, FLUSHING (flush), ARTHRALGIA (joint pain), CHILLS (chills), HEADACHE (headache), MYALGIA (muscle aches) and PYREXIA (fever) had resolved. At the time of the report, LYMPHADENOPATHY (swollen lymph nodes above clavicle) outcome was unknown.            No relevant concomitant medications were reported.  Treatment details included Motrin.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: flush; joint pain; chills; headache; swollen lymph nodes above clavicle; muscle aches; fever; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (flush), ARTHRALGIA (joint pain), CHILLS (chills), HEADACHE (headache) and LYMPHADENOPATHY (swollen lymph nodes above clavicle) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced FLUSHING (flush), ARTHRALGIA (joint pain), CHILLS (chills), HEADACHE (headache), LYMPHADENOPATHY (swollen lymph nodes above clavicle), MYALGIA (muscle aches) and PYREXIA (fever). On 05-Mar-2021, FLUSHING (flush), ARTHRALGIA (joint pain), CHILLS (chills), HEADACHE (headache), MYALGIA (muscle aches) and PYREXIA (fever) had resolved. At the time of the report, LYMPHADENOPATHY (swollen lymph nodes above clavicle) outcome was unknown.            No relevant concomitant medications were reported.  Treatment details included Motrin.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Hot flush
Clinical narrative: hot flashes; injection site looks inflamed and is warm to touch; injection site looks inflamed and is warm to touch; joint pain; chills; fatigue; headache; redness around and above the injection site; lymph nodes sore and tender; muscle pain; feeling of nausea; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (hot flashes), ARTHRALGIA (joint pain), CHILLS (chills), FATIGUE (fatigue) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Fibromyalgia.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HOT FLUSH (hot flashes), ARTHRALGIA (joint pain), CHILLS (chills), FATIGUE (fatigue), HEADACHE (headache), VACCINATION SITE ERYTHEMA (redness around and above the injection site), VACCINATION SITE INFLAMMATION (injection site looks inflamed and is warm to touch), VACCINATION SITE WARMTH (injection site looks inflamed and is warm to touch), LYMPHADENOPATHY (lymph nodes sore and tender), MYALGIA (muscle pain) and NAUSEA (feeling of nausea). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, HOT FLUSH (hot flashes), ARTHRALGIA (joint pain), CHILLS (chills), FATIGUE (fatigue), HEADACHE (headache), VACCINATION SITE ERYTHEMA (redness around and above the injection site), VACCINATION SITE INFLAMMATION (injection site looks inflamed and is warm to touch), VACCINATION SITE WARMTH (injection site looks inflamed and is warm to touch), LYMPHADENOPATHY (lymph nodes sore and tender), MYALGIA (muscle pain) and NAUSEA (feeling of nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Myalgia, Nausea, Vaccination site erythema, Vaccination site inflammation
Clinical narrative: hot flashes; injection site looks inflamed and is warm to touch; injection site looks inflamed and is warm to touch; joint pain; chills; fatigue; headache; redness around and above the injection site; lymph nodes sore and tender; muscle pain; feeling of nausea; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (hot flashes), ARTHRALGIA (joint pain), CHILLS (chills), FATIGUE (fatigue) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Fibromyalgia.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HOT FLUSH (hot flashes), ARTHRALGIA (joint pain), CHILLS (chills), FATIGUE (fatigue), HEADACHE (headache), VACCINATION SITE ERYTHEMA (redness around and above the injection site), VACCINATION SITE INFLAMMATION (injection site looks inflamed and is warm to touch), VACCINATION SITE WARMTH (injection site looks inflamed and is warm to touch), LYMPHADENOPATHY (lymph nodes sore and tender), MYALGIA (muscle pain) and NAUSEA (feeling of nausea). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, HOT FLUSH (hot flashes), ARTHRALGIA (joint pain), CHILLS (chills), FATIGUE (fatigue), HEADACHE (headache), VACCINATION SITE ERYTHEMA (redness around and above the injection site), VACCINATION SITE INFLAMMATION (injection site looks inflamed and is warm to touch), VACCINATION SITE WARMTH (injection site looks inflamed and is warm to touch), LYMPHADENOPATHY (lymph nodes sore and tender), MYALGIA (muscle pain) and NAUSEA (feeling of nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: hot flashes; injection site looks inflamed and is warm to touch; injection site looks inflamed and is warm to touch; joint pain; chills; fatigue; headache; redness around and above the injection site; lymph nodes sore and tender; muscle pain; feeling of nausea; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (hot flashes), ARTHRALGIA (joint pain), CHILLS (chills), FATIGUE (fatigue) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Fibromyalgia.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HOT FLUSH (hot flashes), ARTHRALGIA (joint pain), CHILLS (chills), FATIGUE (fatigue), HEADACHE (headache), VACCINATION SITE ERYTHEMA (redness around and above the injection site), VACCINATION SITE INFLAMMATION (injection site looks inflamed and is warm to touch), VACCINATION SITE WARMTH (injection site looks inflamed and is warm to touch), LYMPHADENOPATHY (lymph nodes sore and tender), MYALGIA (muscle pain) and NAUSEA (feeling of nausea). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, HOT FLUSH (hot flashes), ARTHRALGIA (joint pain), CHILLS (chills), FATIGUE (fatigue), HEADACHE (headache), VACCINATION SITE ERYTHEMA (redness around and above the injection site), VACCINATION SITE INFLAMMATION (injection site looks inflamed and is warm to touch), VACCINATION SITE WARMTH (injection site looks inflamed and is warm to touch), LYMPHADENOPATHY (lymph nodes sore and tender), MYALGIA (muscle pain) and NAUSEA (feeling of nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site rash, Maternal exposure during pregnancy, Pregnancy test
Clinical narrative: Rash at injection site; Redness at injection site; Pregnant; Soreness at injeciton site; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Soreness at injeciton site), INJECTION SITE RASH (Rash at injection site), INJECTION SITE ERYTHEMA (Redness at injection site) and EXPOSURE DURING PREGNANCY (Pregnant) in a 32-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 11-Sep-2020 and the estimated date of delivery was 12-Jun-2021. In October 2020, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). On 12-Feb-2021, the patient experienced INJECTION SITE PAIN (Soreness at injeciton site). On 19-Feb-2021, the patient experienced INJECTION SITE RASH (Rash at injection site) and INJECTION SITE ERYTHEMA (Redness at injection site). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-second week of the pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. In October 2020, EXPOSURE DURING PREGNANCY (Pregnant) had resolved. At the time of the report, INJECTION SITE PAIN (Soreness at injeciton site), INJECTION SITE RASH (Rash at injection site) and INJECTION SITE ERYTHEMA (Redness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was reported.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test
Clinical narrative: Pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) in a 27-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     Concomitant products included PRE NATAL FORMULA, CHLORAL HYDRATE, PROMETHAZINE HYDROCHLORIDE (PHENERGAN AND CHLORAL HYDRATE) and DOXYLAMINE SUCCINATE (UNISOM 2) for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 13-Jun-2020 and the estimated date of delivery was 18-Mar-2021. On 24-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-sixth week of the pregnancy.  On 24-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Jul-2020, Pregnancy test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The estimated date of conception was 25 Jun 2020. Glucose tolerance test and ultrasound scan was performed results unknown. Patient had previous one pregnancy on 04 Sep 2018.
Age: 72.0
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: feels like a bug bite, hasn't gone away and hasn't got any bigger, more annoying than anything else, half the time forget about it; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Mar-2021 and was forwarded to Moderna on 08-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (feels like a bug bite, hasn't gone away and hasn't got any bigger, more annoying than anything else, half the time forget about it) in a 72-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (feels like a bug bite, hasn't gone away and hasn't got any bigger, more annoying than anything else, half the time forget about it). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date for Vaccination adverse reaction, at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (feels like a bug bite, hasn't gone away and hasn't got any bigger, more annoying than anything else, half the time forget about it) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  The patient received the first dose of the Moderna COVID-19 Vaccine on the upper left arm about 8 days prior to the day of the call and experienced something that feels like a bug bite. The patient said it is not serious and started the first day. Has not gone away and has not got any bigger.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Arthropod sting, Chills, Erythema, Fatigue, Headache
Clinical narrative: Headache; Feels like a bee sting; Soreness; Red; Itching; Whole arm is swollen; Tired; Had fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ARTHROPOD STING (Feels like a bee sting), PAIN (Soreness), ERYTHEMA (Red), PRURITUS (Itching) and PERIPHERAL SWELLING (Whole arm is swollen) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was Provided.  Concomitant products included IRBESARTAN and ATORVASTATIN for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced ARTHROPOD STING (Feels like a bee sting), PAIN (Soreness), ERYTHEMA (Red), PRURITUS (Itching), PERIPHERAL SWELLING (Whole arm is swollen), FATIGUE (Tired), PYREXIA (Had fever) and CHILLS (Chills). On 06-Mar-2021, the patient experienced HEADACHE (Headache). At the time of the report, ARTHROPOD STING (Feels like a bee sting), PAIN (Soreness), ERYTHEMA (Red), PRURITUS (Itching), PERIPHERAL SWELLING (Whole arm is swollen), FATIGUE (Tired), PYREXIA (Had fever), CHILLS (Chills) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Treatment Information provided.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Peripheral swelling, Pruritus, Pyrexia
Clinical narrative: Headache; Feels like a bee sting; Soreness; Red; Itching; Whole arm is swollen; Tired; Had fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ARTHROPOD STING (Feels like a bee sting), PAIN (Soreness), ERYTHEMA (Red), PRURITUS (Itching) and PERIPHERAL SWELLING (Whole arm is swollen) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was Provided.  Concomitant products included IRBESARTAN and ATORVASTATIN for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced ARTHROPOD STING (Feels like a bee sting), PAIN (Soreness), ERYTHEMA (Red), PRURITUS (Itching), PERIPHERAL SWELLING (Whole arm is swollen), FATIGUE (Tired), PYREXIA (Had fever) and CHILLS (Chills). On 06-Mar-2021, the patient experienced HEADACHE (Headache). At the time of the report, ARTHROPOD STING (Feels like a bee sting), PAIN (Soreness), ERYTHEMA (Red), PRURITUS (Itching), PERIPHERAL SWELLING (Whole arm is swollen), FATIGUE (Tired), PYREXIA (Had fever), CHILLS (Chills) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Treatment Information provided.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Wrong technique in device usage process
Clinical narrative: Vaccine thawed for only 45 minutes; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Mar-2021 and was forwarded to Moderna on 09-Mar-2021.    This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of WRONG TECHNIQUE IN DEVICE USAGE PROCESS (Vaccine thawed for only 45 minutes) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for an unknown indication.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced WRONG TECHNIQUE IN DEVICE USAGE PROCESS (Vaccine thawed for only 45 minutes). On 08-Mar-2021, WRONG TECHNIQUE IN DEVICE USAGE PROCESS (Vaccine thawed for only 45 minutes) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Influenza like illness, Injection site erythema, Injection site swelling
Clinical narrative: Felt very shaky; Hot to touch injection site; It was like she was having the flu; Swollen injection site; Bad Headache; Very tired; Red injection site; This spontaneous case was reported by a consumer and describes the occurrence of NERVOUSNESS (Felt very shaky), INJECTION SITE WARMTH (Hot to touch injection site), INFLUENZA LIKE ILLNESS (It was like she was having the flu), INJECTION SITE SWELLING (Swollen injection site) and HEADACHE (Bad Headache) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced NERVOUSNESS (Felt very shaky), INJECTION SITE WARMTH (Hot to touch injection site), INFLUENZA LIKE ILLNESS (It was like she was having the flu), INJECTION SITE SWELLING (Swollen injection site), HEADACHE (Bad Headache), FATIGUE (Very tired) and INJECTION SITE ERYTHEMA (Red injection site). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, NERVOUSNESS (Felt very shaky), INJECTION SITE WARMTH (Hot to touch injection site), INFLUENZA LIKE ILLNESS (It was like she was having the flu), INJECTION SITE SWELLING (Swollen injection site), HEADACHE (Bad Headache), FATIGUE (Very tired) and INJECTION SITE ERYTHEMA (Red injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication not reported.
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Nervousness
Clinical narrative: Felt very shaky; Hot to touch injection site; It was like she was having the flu; Swollen injection site; Bad Headache; Very tired; Red injection site; This spontaneous case was reported by a consumer and describes the occurrence of NERVOUSNESS (Felt very shaky), INJECTION SITE WARMTH (Hot to touch injection site), INFLUENZA LIKE ILLNESS (It was like she was having the flu), INJECTION SITE SWELLING (Swollen injection site) and HEADACHE (Bad Headache) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced NERVOUSNESS (Felt very shaky), INJECTION SITE WARMTH (Hot to touch injection site), INFLUENZA LIKE ILLNESS (It was like she was having the flu), INJECTION SITE SWELLING (Swollen injection site), HEADACHE (Bad Headache), FATIGUE (Very tired) and INJECTION SITE ERYTHEMA (Red injection site). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, NERVOUSNESS (Felt very shaky), INJECTION SITE WARMTH (Hot to touch injection site), INFLUENZA LIKE ILLNESS (It was like she was having the flu), INJECTION SITE SWELLING (Swollen injection site), HEADACHE (Bad Headache), FATIGUE (Very tired) and INJECTION SITE ERYTHEMA (Red injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication not reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Dysgeusia, Headache, Heart rate increased
Clinical narrative: feels very weak; shaking; can't eat; strong metal taste , like she was "chewing on stainless steel"; bothered by smell"; the inside of her mouth was covered with blisters; increased heart rate; worse flu she could have"; terrible headache; fever; vomiting; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Mar-2021 and was forwarded to Moderna on 08-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (feels very weak), TREMOR (shaking), DECREASED APPETITE (can't eat), DYSGEUSIA (strong metal taste , like she was "chewing on stainless steel") and PAROSMIA (bothered by smell") in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes mellitus, Allergic reaction to analgesics (Allergies include codeine and sulfa drugs.) and Sulfonamide allergy. Concomitant products included ISOPHANE INSULIN (NPH INSULIN) for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced ASTHENIA (feels very weak), TREMOR (shaking), DECREASED APPETITE (can't eat), DYSGEUSIA (strong metal taste , like she was "chewing on stainless steel"), PAROSMIA (bothered by smell"), MOUTH ULCERATION (the inside of her mouth was covered with blisters), HEART RATE INCREASED (increased heart rate), INFLUENZA LIKE ILLNESS (worse flu she could have"), HEADACHE (terrible headache), PYREXIA (fever) and VOMITING (vomiting). At the time of the report, ASTHENIA (feels very weak), TREMOR (shaking), DECREASED APPETITE (can't eat), DYSGEUSIA (strong metal taste , like she was "chewing on stainless steel"), PAROSMIA (bothered by smell"), MOUTH ULCERATION (the inside of her mouth was covered with blisters), HEART RATE INCREASED (increased heart rate), INFLUENZA LIKE ILLNESS (worse flu she could have"), HEADACHE (terrible headache), PYREXIA (fever) and VOMITING (vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.